2021-05-09
Published Date
Healthcare
Industry
105
Pages
The global Pneumonia Vaccine market is growing with significant growth from last couple of years and in the year 2020, the market of Pneumonia Vaccine was valued at USD XX Million and is expected to reach USD XXX million by the end of the year 2027. , The report is designed to offer very important and crucial information about the Pneumonia Vaccine market and industry. For the purpose of this study, the market of Pneumonia Vaccine has been segmented into type, application, regions and countries. Each segment of the report will provide a detailed analysis of the market and in terms of quantitative information, the report will offer market revenue (USD Million), market share in %, market CAGR from 2021 to 2027. The report also provides a detailed qualitative analysis of the Pneumonia Vaccine market which includes Market Drivers to explain the driving factors of the market and demand, Market Challenges to explain the restraints of the market and growth and Market Opportunities to explain the upcoming trends and opportunities left for the newcomers of the market and where can the existing companies focus in order to gain competitive advantage. The Pneumonia Vaccine report also provides a detailed Porter's Five Forces, Micro and Macro Economic analysis which can help the readers and the users of the report to understand and draw a sound business decision. The readers of the report will have a deep , insightful analysis that will help in understanding the market size, market share, CAGR, country specific analysis and market share for Pneumonia Vaccine market. Market Segmentation One of the very important chapter of Pneumonia Vaccine market report is competitive analysis. In this chapter, we have presented a detailed overview of the competition and have provided the market revenue of each company along with the market share. The companies mentioned in the report are: Pfizer Inc. Glaxosmithkline Plc. Merck & Co. Inc. Sanofi Pasteur Serum Institute of India Pvt. Ltd. Johnson & Johnson Astellas Pharma Inc. Astrazeneca Plc. CSL Limited Emergent Biosolutions Note: We can also add companies which are not part of the above list Global Pneumonia Vaccine Market Analysis By Type Pneumococcal Conjugate Vaccine (PCV13) Pneumococcal Polysaccharide Vaccine (PPSV23) In the year 2020, Pneumococcal Conjugate Vaccine (PCV13) segment had XX% of market share and in terms of value, the Pneumococcal Conjugate Vaccine (PCV13) market was valued at USD XX Million. , It is expected that Pneumococcal Conjugate Vaccine (PCV13) will have XX% of market share by the end of year 2027 and the incremental growth from 2021 till 2027 is expected to be USD XX Million. Global Pneumonia Vaccine Market Analysis By Application Pneumonia Meningitis Sepsis Pneumonia segment is expected to account for XX% of market share by the end of year 2027 from XX% in 2020. The Pneumonia segment is expected to grow at USD XX million by the end of year 2027. The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The following regions has been further bifurcated into countries to provide an insightful analysis for the readers. Global Pneumonia Vaccine market: regional analysis, the major regions covered in the report are: United States China European Union Rest of World (Japan, Korea, India and Southeast Asia) The study objectives are: To analyze and research the Pneumonia Vaccine Market status and future forecast. To present the key Pneumonia Vaccine Market analysis of companies and present revenue, market share, and recent development for key players. To split the breakdown data by regions, type, companies and applications. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. To identify significant trends, drivers, influence factors in global and regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. Frequently Asked Questions - FAQ: How big is the opportunity for the Pneumonia Vaccine market What are the recent industry development that can be implemented to generate additional revenue streams Who are the major players operating in the Pneumonia Vaccine market Which companies are the front runners
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Major Manufacturers Covered in This Report 1.3 Market Segment by Type 1.3.1 Global Pneumonia Vaccine Market Size Growth Rate by Type (2021-2027) 1.3.2 Pneumococcal Conjugate Vaccine (PCV13) 1.3.3 Pneumococcal Polysaccharide Vaccine (PPSV23) 1.4 Market Segment by Application 1.4.1 Global Pneumonia Vaccine Market Share by Application (2021-2027) 1.4.2 Pneumonia 1.4.3 Meningitis 1.4.4 Sepsis 1.5 Study Objectives 1.6 Years Considered 2 Global Growth Trends 2.1 Global Pneumonia Vaccine Market Size 2.1.1 Global Pneumonia Vaccine Revenue 2016-2027 2.1.2 Global Pneumonia Vaccine Sales 2016-2027 2.2 Pneumonia Vaccine Growth Rate by Regions 2.2.1 Global Pneumonia Vaccine Sales by Regions 2016-2020 2.2.2 Global Pneumonia Vaccine Revenue by Regions 2016-2020 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 3 Market Share by Manufacturers 3.1 Pneumonia Vaccine Sales by Manufacturers 3.1.1 Pneumonia Vaccine Sales by Manufacturers 2016-2020 3.1.2 Pneumonia Vaccine Sales Market Share by Manufacturers 2016-2020 3.2 Revenue by Manufacturers 3.2.1 Pneumonia Vaccine Revenue by Manufacturers (2016-2020) 3.2.2 Pneumonia Vaccine Revenue Share by Manufacturers (2016-2020) 3.2.3 Global Pneumonia Vaccine Market Concentration Ratio (CR5 and HHI) 3.3 Pneumonia Vaccine Price by Manufacturers 3.4 Key Manufacturers Pneumonia Vaccine Plants/Factories Distribution and Area Served 3.5 Date of Key Manufacturers Enter into Pneumonia Vaccine Market 3.6 Key Manufacturers Pneumonia Vaccine Product Offered 3.7 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Sales and Revenue for Each Type 4.1.1 Pneumococcal Conjugate Vaccine (PCV13) Sales and Revenue (2016-2020) 4.1.2 Pneumococcal Polysaccharide Vaccine (PPSV23) Sales and Revenue (2016-2020) 4.2 Global Pneumonia Vaccine Sales Market Share by Type 4.3 Global Pneumonia Vaccine Revenue Market Share by Type 4.4 Pneumonia Vaccine Price by Type 5 Market Size by Application 5.1 Overview 5.2 Global Pneumonia Vaccine Sales by Application 6 United States 6.1 United States Pneumonia Vaccine Breakdown Data by Company 6.2 United States Pneumonia Vaccine Breakdown Data by Type 6.3 United States Pneumonia Vaccine Breakdown Data by Application 7 European Union 7.1 European Union Pneumonia Vaccine Breakdown Data by Company 7.2 European Union Pneumonia Vaccine Breakdown Data by Type 7.3 European Union Pneumonia Vaccine Breakdown Data by Application 8 China 8.1 China Pneumonia Vaccine Breakdown Data by Company 8.2 China Pneumonia Vaccine Breakdown Data by Type 8.3 China Pneumonia Vaccine Breakdown Data by Application 9 Rest of World 9.1 Rest of World Pneumonia Vaccine Breakdown Data by Company 9.2 Rest of World Pneumonia Vaccine Breakdown Data by Type 9.3 Rest of World Pneumonia Vaccine Breakdown Data by Application 9.4 Rest of World Pneumonia Vaccine Breakdown Data by Countries 9.4.1 Rest of World Pneumonia Vaccine Sales by Countries 9.4.2 Rest of World Pneumonia Vaccine Revenue by Countries 9.4.3 Japan 9.4.4 Korea 9.4.5 India 9.4.6 Southeast Asia 10 Company Profiles 10.1 Pfizer Inc. 10.1.1 Pfizer Inc. Company Details 10.1.2 Company Description and Business Overview 10.1.3 Sales, Revenue and Market Share of Pneumonia Vaccine 10.1.4 Pneumonia Vaccine Product Introduction 10.1.5 Pfizer Inc. Recent Development 10.2 Glaxosmithkline Plc. 10.2.1 Glaxosmithkline Plc. Company Details 10.2.2 Company Description and Business Overview 10.2.3 Sales, Revenue and Market Share of Pneumonia Vaccine 10.2.4 Pneumonia Vaccine Product Introduction 10.2.5 Glaxosmithkline Plc. Recent Development 10.3 Merck & Co., Inc. 10.3.1 Merck & Co., Inc. Company Details 10.3.2 Company Description and Business Overview 10.3.3 Sales, Revenue and Market Share of Pneumonia Vaccine 10.3.4 Pneumonia Vaccine Product Introduction 10.3.5 Merck & Co., Inc. Recent Development 10.4 Sanofi Pasteur 10.4.1 Sanofi Pasteur Company Details 10.4.2 Company Description and Business Overview 10.4.3 Sales, Revenue and Market Share of Pneumonia Vaccine 10.4.4 Pneumonia Vaccine Product Introduction 10.4.5 Sanofi Pasteur Recent Development 10.5 Serum Institute of India Pvt. Ltd. 10.5.1 Serum Institute of India Pvt. Ltd. Company Details 10.5.2 Company Description and Business Overview 10.5.3 Sales, Revenue and Market Share of Pneumonia Vaccine 10.5.4 Pneumonia Vaccine Product Introduction 10.5.5 Serum Institute of India Pvt. Ltd. Recent Development 10.6 Johnson & Johnson 10.6.1 Johnson & Johnson Company Details 10.6.2 Company Description and Business Overview 10.6.3 Sales, Revenue and Market Share of Pneumonia Vaccine 10.6.4 Pneumonia Vaccine Product Introduction 10.6.5 Johnson & Johnson Recent Development 10.7 Astellas Pharma Inc. 10.7.1 Astellas Pharma Inc. Company Details 10.7.2 Company Description and Business Overview 10.7.3 Sales, Revenue and Market Share of Pneumonia Vaccine 10.7.4 Pneumonia Vaccine Product Introduction 10.7.5 Astellas Pharma Inc. Recent Development 10.8 Astrazeneca Plc. 10.8.1 Astrazeneca Plc. Company Details 10.8.2 Company Description and Business Overview 10.8.3 Sales, Revenue and Market Share of Pneumonia Vaccine 10.8.4 Pneumonia Vaccine Product Introduction 10.8.5 Astrazeneca Plc. Recent Development 10.9 CSL Limited 10.9.1 CSL Limited Company Details 10.9.2 Company Description and Business Overview 10.9.3 Sales, Revenue and Market Share of Pneumonia Vaccine 10.9.4 Pneumonia Vaccine Product Introduction 10.9.5 CSL Limited Recent Development 10.10 Emergent Biosolutions 10.10.1 Emergent Biosolutions Company Details 10.10.2 Company Description and Business Overview 10.10.3 Sales, Revenue and Market Share of Pneumonia Vaccine 10.10.4 Pneumonia Vaccine Product Introduction 10.10.5 Emergent Biosolutions Recent Development 11 Value Chain and Sales Channels Analysis 11.1 Value Chain Analysis 11.2 Sales Channels Analysis 11.2.1 Pneumonia Vaccine Sales Channels 11.2.2 Pneumonia Vaccine Distributors 11.3 Pneumonia Vaccine Customers 12 Market Forecast 12.1 Global Pneumonia Vaccine Sales and Revenue Forecast 2021-2027 12.2 Global Pneumonia Vaccine Sales Forecast by Type 12.3 Global Pneumonia Vaccine Sales Forecast by Application 12.4 Pneumonia Vaccine Forecast by Regions 12.4.1 Global Pneumonia Vaccine Sales Forecast by Regions 2021-2027 12.4.2 Global Pneumonia Vaccine Revenue Forecast by Regions 2021-2027 12.5 United States Market Forecast 12.6 European Union Market Forecast 12.7 China Market Forecast 12.8 Rest of World 12.8.1 Japan 12.8.2 Korea 12.8.3 India 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 DisclaimerList of Tables and Figures
List of Tables and Figures Figure Pneumonia Vaccine Product Picture Table Pneumonia Vaccine Key Market Segments Table Major Manufacturers Pneumonia Vaccine Covered in This Report Table Global Pneumonia Vaccine Market Size Growth Rate by Type 2021-2027 (K Doses) & (Million US$) Figure Global Pneumonia Vaccine Sales Market Shar by Type 2016-2027 Figure Pneumococcal Conjugate Vaccine (PCV13) Figures Table Major Manufacturers of Pneumococcal Conjugate Vaccine (PCV13) Figure Pneumococcal Polysaccharide Vaccine (PPSV23) Figures Table Major Manufacturers of Pneumococcal Polysaccharide Vaccine (PPSV23) Table Global Pneumonia Vaccine Market Share by Application 2021-2027 (K Doses) Figure Pneumonia Use Case Figure Meningitis Use Case Figure Sepsis Use Case Figure Pneumonia Vaccine Report Years Considered Figure Global Pneumonia Vaccine Market Size 2016-2027 (Million US$) Figure Global Pneumonia Vaccine Sales 2016-2020 (K Doses) Table Global Pneumonia Vaccine Market Size by Regions 2016-2020 (K Doses) & (Million US$) Table Global Pneumonia Vaccine Sales by Regions 2016-2020 (K Doses) Table Global Pneumonia Vaccine Sales Market Share by Regions 2016-2020 Figure Global Pneumonia Vaccine Sales Market Share by Regions 2016-2020 Figure Global Pneumonia Vaccine Sales Market Share by Regions in 2020 Table Global Pneumonia Vaccine Revenue by Regions 2016-2020 (Million US$) Table Global Pneumonia Vaccine Revenue Market Share by Regions 2016-2020 Figure Global Pneumonia Vaccine Revenue Market Share by Regions 2016-2020 Figure Global Pneumonia Vaccine Revenue Market Share by Regions in 2020 Table Market Top Trends Table Global Pneumonia Vaccine Sales by Manufacturers (2016-2020) (K Doses) Table Global Pneumonia Vaccine Sales Share by Manufacturers (2016-2020) Figure Global Pneumonia Vaccine Sales Share by Manufacturers in 2020 Table Pneumonia Vaccine Revenue by Manufacturers (2016-2020) (Million USD) Table Pneumonia Vaccine Revenue Share by Manufacturers (2016-2020) Figure Pneumonia Vaccine Value Share by Manufacturers in 2020 Table Global Pneumonia Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Manufacturers Pneumonia Vaccine Price (2016-2020) (USD/Dose) Table Key Manufacturers Pneumonia Vaccine Plants/Factories Distribution Table Key Manufacturers Pneumonia Vaccine Area Served Table Date of Key Manufacturers Enter into Pneumonia Vaccine Market Table Key Manufacturers Pneumonia Vaccine Product Type Table Mergers & Acquisitions, Expansion Plans Table Global Pneumococcal Conjugate Vaccine (PCV13) Sales and Revenue (2016-2020) (K Doses) & (Million US$) Table Global Pneumococcal Polysaccharide Vaccine (PPSV23) Sales and Revenue (2016-2020) (K Doses) & (Million US$) Table Global Pneumonia Vaccine Sales by Type (2016-2020) (K Doses) Table Global Pneumonia Vaccine Sales Share by Type (2016-2020) Figure Global Pneumonia Vaccine Sales Market Share by Type (2016-2020) Figure Global Pneumonia Vaccine Sales Market Share by Type in 2020 Table Global Pneumonia Vaccine Revenue by Type (2016-2020) (Million US$) Table Global Pneumonia Vaccine Revenue Share by Type (2016-2020) Figure Global Pneumonia Vaccine Revenue Market Share by Type (2016-2020) Figure Global Pneumonia Vaccine Revenue Market Share by Type in 2020 Table Pneumonia Vaccine Price by Type 2016-2020 (USD/Dose) Table Global Pneumonia Vaccine Sales by Application (2016-2020) (K Doses) Table Global Pneumonia Vaccine Sales Share by Application (2016-2020) Figure Global Sales Pneumonia Vaccine Market Share by Application (2016-2020) Figure Global Sales Pneumonia Vaccine Market Share by Application (2016-2020) Figure United States Pneumonia Vaccine Sales Growth Rate 2016-2020 (K Doses) Figure United States Pneumonia Vaccine Revenue Growth Rate 2016-2020 (Million US$) Table United States Pneumonia Vaccine Sales by Company (2016-2020) (K Doses) Table United States Pneumonia Vaccine Sales Market Share by Company (2016-2020) Figure United States Pneumonia Vaccine Sales Market Share by Company in 2020 Table United States Pneumonia Vaccine Sales by Type (2016-2020) (K Doses) Table United States Pneumonia Vaccine Sales Market Share by Type (2016-2020) Figure United States Pneumonia Vaccine Market Share by Type in 2020 Table United States Pneumonia Vaccine Sales by Application (2016-2020) (K Doses) Table United States Pneumonia Vaccine Sales Market Share by Application (2016-2020) Figure United States Pneumonia Vaccine Market Share by Application in 2020 Figure European Union Pneumonia Vaccine Sales Growth Rate 2016-2020 (K Doses) Figure European Union Pneumonia Vaccine Revenue Growth Rate 2016-2020 (Million US$) Table European Union Pneumonia Vaccine Sales by Company (2016-2020) (K Doses) Table European Union Pneumonia Vaccine Sales Market Share by Company (2016-2020) Figure European Union Pneumonia Vaccine Sales Market Share by Company in 2020 Table European Union Pneumonia Vaccine Sales by Type (2016-2020) (K Doses) Table European Union Pneumonia Vaccine Sales Market Share by Type (2016-2020) Figure European Union Pneumonia Vaccine Market Share by Type Table European Union Pneumonia Vaccine Sales by Application (2016-2020) (K Doses) Table European Union Pneumonia Vaccine Sales Market Share by Application (2016-2020) Figure European Union Pneumonia Vaccine Market Share by Application Figure China Pneumonia Vaccine Sales Growth Rate 2016-2020 (K Doses) Figure China Pneumonia Vaccine Revenue Growth Rate 2016-2020 (Million US$) Table China Pneumonia Vaccine Sales by Company (2016-2020) (K Doses) Table China Pneumonia Vaccine Sales Market Share by Company (2016-2020) Figure China Pneumonia Vaccine Sales Market Share by Company in 2020 Table China Pneumonia Vaccine Sales by Type (2016-2020) (K Doses) Table China Pneumonia Vaccine Sales Market Share by Type (2016-2020) Figure China Pneumonia Vaccine Market Share by Type in 2020 Table China Pneumonia Vaccine Sales by Application (2016-2020) (K Doses) Table China Pneumonia Vaccine Sales Market Share by Application (2016-2020) Figure China Pneumonia Vaccine Market Share by Application in 2020 Figure Rest of World Pneumonia Vaccine Sales Growth Rate 2016-2020 (K Doses) Figure Rest of World Pneumonia Vaccine Revenue Growth Rate 2016-2020 (Million US$) Table Rest of World Pneumonia Vaccine Sales by Company (2016-2020) (K Doses) Table Rest of World Pneumonia Vaccine Sales Market Share by Company (2016-2020) Figure Rest of World Pneumonia Vaccine Sales Market Share by Company in 2020 Table Rest of World Pneumonia Vaccine Sales by Type (2016-2020) (K Doses) Table Rest of World Pneumonia Vaccine Sales Market Share by Type (2016-2020) Figure Rest of World Pneumonia Vaccine Market Share by Type in 2020 Table Rest of World Pneumonia Vaccine Sales by Application (2016-2020) (K Doses) Table Rest of World Pneumonia Vaccine Sales Market Share by Application (2016-2020) Figure Rest of World Pneumonia Vaccine Market Share by Application in 2020 Table Rest of World Pneumonia Vaccine Sales by Countries (2016-2020) (K Doses) Table Rest of World Pneumonia Vaccine Sales Market Share by Countries (2016-2020) Figure Rest of World Pneumonia Vaccine Sales Market Share by Countries in 2020 Table Rest of World Pneumonia Vaccine Revenue by Countries (2016-2020) (Million US$) Table Rest of World Pneumonia Vaccine Revenue Market Share by Countries (2016-2020) Figure Rest of World Pneumonia Vaccine Revenue Market Share by Countries in 2020 Figure Japan Pneumonia Vaccine Sales Growth Rate (2016-2020) (K Doses) Figure Japan Pneumonia Vaccine Revenue Growth Rate (2016-2020) (K Doses) Figure Korea Pneumonia Vaccine Sales Growth Rate (2016-2020) (K Doses) Figure Korea Pneumonia Vaccine Revenue Growth Rate (2016-2020) (K Doses) Figure India Pneumonia Vaccine Sales Growth Rate (2016-2020) (K Doses) Figure India Pneumonia Vaccine Revenue Growth Rate (2016-2020) (K Doses) Figure Southeast Asia Pneumonia Vaccine Sales Growth Rate (2016-2020) (K Doses) Figure Southeast Asia Pneumonia Vaccine Revenue Growth Rate (2016-2020) (K Doses) Table Pfizer Inc. Company Details Table Pfizer Inc. Description and Business Overview Table Pfizer Inc. Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2020) Table Pfizer Inc. Pneumonia Vaccine Sales Growth Rate (2016-2020) Table Pfizer Inc. Pneumonia Vaccine Sales Market Share in Global Market Table Pfizer Inc. Recent Development Table Glaxosmithkline Plc. Company Details Table Glaxosmithkline Plc. Description and Business Overview Table Glaxosmithkline Plc. Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2020) Table Glaxosmithkline Plc. Pneumonia Vaccine Sales Growth Rate (2016-2020) Table Glaxosmithkline Plc. Pneumonia Vaccine Sales Market Share in Global Market Table Glaxosmithkline Plc. Recent Development Table Merck & Co., Inc. Company Details Table Merck & Co., Inc. Description and Business Overview Table Merck & Co., Inc. Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2020) Table Merck & Co., Inc. Pneumonia Vaccine Sales Growth Rate (2016-2020) Table Merck & Co., Inc. Pneumonia Vaccine Sales Market Share in Global Market Table Merck & Co., Inc. Recent Development Table Sanofi Pasteur Company Details Table Sanofi Pasteur Description and Business Overview Table Sanofi Pasteur Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2020) Table Sanofi Pasteur Pneumonia Vaccine Sales Growth Rate (2016-2020) Table Sanofi Pasteur Pneumonia Vaccine Sales Market Share in Global Market Table Sanofi Pasteur Recent Development Table Serum Institute of India Pvt. Ltd. Company Details Table Serum Institute of India Pvt. Ltd. Description and Business Overview Table Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2020) Table Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales Growth Rate (2016-2020) Table Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales Market Share in Global Market Table Serum Institute of India Pvt. Ltd. Recent Development Table Johnson & Johnson Company Details Table Johnson & Johnson Description and Business Overview Table Johnson & Johnson Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2020) Table Johnson & Johnson Pneumonia Vaccine Sales Growth Rate (2016-2020) Table Johnson & Johnson Pneumonia Vaccine Sales Market Share in Global Market Table Johnson & Johnson Recent Development Table Astellas Pharma Inc. Company Details Table Astellas Pharma Inc. Description and Business Overview Table Astellas Pharma Inc. Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2020) Table Astellas Pharma Inc. Pneumonia Vaccine Sales Growth Rate (2016-2020) Table Astellas Pharma Inc. Pneumonia Vaccine Sales Market Share in Global Market Table Astellas Pharma Inc. Recent Development Table Astrazeneca Plc. Company Details Table Astrazeneca Plc. Description and Business Overview Table Astrazeneca Plc. Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2020) Table Astrazeneca Plc. Pneumonia Vaccine Sales Growth Rate (2016-2020) Table Astrazeneca Plc. Pneumonia Vaccine Sales Market Share in Global Market Table Astrazeneca Plc. Recent Development Table CSL Limited Company Details Table CSL Limited Description and Business Overview Table CSL Limited Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2020) Table CSL Limited Pneumonia Vaccine Sales Growth Rate (2016-2020) Table CSL Limited Pneumonia Vaccine Sales Market Share in Global Market Table CSL Limited Recent Development Table Emergent Biosolutions Company Details Table Emergent Biosolutions Description and Business Overview Table Emergent Biosolutions Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2020) Table Emergent Biosolutions Pneumonia Vaccine Sales Growth Rate (2016-2020) Table Emergent Biosolutions Pneumonia Vaccine Sales Market Share in Global Market Table Emergent Biosolutions Recent Development Figure Pneumonia Vaccine Value Chain Table Pneumonia Vaccine Distributors List Table Pneumonia Vaccine Customers List Table Global Pneumonia Vaccine Sales Forecast 2021-2027 (K Doses) & (Million US$) Figure Global Pneumonia Vaccine Sales Forecast 2021-2027 (K Doses) Figure Global Pneumonia Vaccine Revenue Forecast 2021-2027 (Million US$) Table Global Pneumonia Vaccine Sales Forecast by Type 2021-2027 (K Doses) Figure Global Pneumonia Vaccine Sales Forecast by Type 2021-2027 (K Doses) Figure Global Pneumonia Vaccine Sales Market Share Forecast by Type 2021-2027 Table Global Pneumonia Vaccine Sales Forecast by Application 2021-2027 (K Doses) Figure Global Pneumonia Vaccine Sales Forecast by Application 2021-2027 (K Doses) Figure Global Pneumonia Vaccine Sales Market Share Forecast by Application 2021-2027 Table Global Pneumonia Vaccine Sales Forecast by Regions 2021-2027 (K Doses) Figure Global Pneumonia Vaccine Sales Forecast by Regions 2021-2027 (K Doses) Figure Global Pneumonia Vaccine Sales Market Share Forecast by Regions 2021-2027 Table Global Pneumonia Vaccine Revenue Forecast by Regions 2021-2027 (K Doses) Figure Global Pneumonia Vaccine Revenue Forecast by Regions 2021-2027 (K Doses) Figure Global Pneumonia Vaccine Revenue Market Share Forecast by Regions 2021-2027 Figure United States Pneumonia Vaccine Sales Forecast 2021-2027 (K Doses) Figure United States Pneumonia Vaccine Revenue Forecast 2021-2027 (Million US$) Figure European Union Pneumonia Vaccine Sales Forecast 2021-2027 (K Doses) Figure European Union Pneumonia Vaccine Revenue Forecast 2021-2027 (Million US$) Figure China Pneumonia Vaccine Sales Forecast 2021-2027 (K Doses) Figure China Pneumonia Vaccine Revenue Forecast 2021-2027 (Million US$) Figure Japan Pneumonia Vaccine Sales Forecast 2021-2027 (K Doses) Figure Japan Pneumonia Vaccine Revenue Forecast 2021-2027 (Million US$) Figure Korea Pneumonia Vaccine Sales Forecast 2021-2027 (K Doses) Figure Korea Pneumonia Vaccine Revenue Forecast 2021-2027 (Million US$) Figure India Pneumonia Vaccine Sales Forecast 2021-2027 (K Doses) Figure India Pneumonia Vaccine Revenue Forecast 2021-2027 (Million US$) Figure Southeast Asia Pneumonia Vaccine Sales Forecast 2021-2027 (K Doses) Figure Southeast Asia Pneumonia Vaccine Revenue Forecast 2021-2027 (Million US$) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation